Enjoying free speech since 1984. Your daily dose of anti-propaganda!
Tags: stock exchange, viral infections, biomarkers, mers, sars, Alivecel, new company, Hemp & Wood S.A., joint ventures, implant, coronavirus test, coronavirus in Poland, coronavirus, sars-cov-2, covid-19
Signing of an agreement for the establishment of a biotechnology company producing implants enabling …
That is an interesting perspective, isn’t it?
The timing is right for everyone to understand what Donald Trump is doing, and try to decrypt the ambiguity of how he is doing it. The controversial President has a much clearer agenda …
Então o objectivo não era apenas aplanar a curva? Mas agora que a curva aplanou já queremos evitar infectados, internados, doentes em UCI, mortos. Mas não tinham explicado que isso era inevitável?
Source: Fomos enganados – Observador…
Noam Chomsky is one of the most highly respected intellectuals in the world. The New York Times said he’s the most important thinker of our current era. One of the major things he’s done is calling out and analyzing the …
A bit old, but important and still valid!
Source: Corona 34 – Schwindelambulanz Sinsheim / Dr. Bodo Schiffmann…
This video had been originally published by Dr. Bodo Schiffmann on April 23rd 2020 and was removed by YouTube and banned on Facebook.
Source: Corona35 – Schwindelambulanz Sinsheim / Dr. Bodo Schiffmann…
PubMed
Silver nanoparticles (AgNPs) have attracted much attention as antimicrobial agents and have demonstrated efficient inhibitory activity against various viruses, including human immunodeficiency virus, hepatitis B virus, and Tacaribe virus. In this study, we investigated if AgNPs could have antiviral …
PubMed
The interaction between silver nanoparticles and viruses is attracting great interest due to the potential antiviral activity of these particles, and is the subject of much research effort in the treatment of infectious diseases. In this work, we demonstrate …
PubMed
Virus infections pose significant global health challenges, especially in view of the fact that the emergence of resistant viral strains and the adverse side effects associated with prolonged use continue to slow down the application of effective antiviral therapies. …
The answer is probably yes, based on the evidence I’m going to show you – but we won’t know for sure until studies are done. Three are now underway right now, two giving those with SARS (severe acute respiratory syndrome), …
